MAB8261
Anti-Influenza A Antibody, H1N1, clone 9B3.2
clone 9B3.2, Chemicon®, from mouse
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
9B3.2, monoclonal
Species reactivity:
human
Application:
immunofluorescence
Technique(s):
immunofluorescence: suitable
Citations:
10
产品名称
Anti-Influenza A Antibody, H1N1, clone 9B3.2, clone 9B3.2, Chemicon®, from mouse
biological source
mouse
antibody form
purified immunoglobulin
clone
9B3.2, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
isotype
IgG2a
shipped in
wet ice
Quality Level
Immunogen
Influenza blend
Epitope: H1N1
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Physical form
Format: Purified
Purified immunoglobulin. Liquid in 0.02 M Phosphate Buffer + 0.25 M Sodium Chloride + 0.1% Sodium Azide, pH = 7.6
Application
IF
Optimal dilutions must be determined by end user
Optimal dilutions must be determined by end user
Research Category
Infectious Diseases
Infectious Diseases
Research Sub Category
Infectious Diseases - Viral
Infectious Diseases - Viral
This Anti-Influenza A Antibody, H1N1, clone 9B3.2 is validated for use in IF for the detection of Influenza A.
Biochem/physiol Actions
Influenza A H1N1 antigen. No reactivity shown to Influenza B strains.
SPECIES REACTIVITY:
Reacts strongly with the following H1N1 strain: Beijing. A/ Texas /36/91, A/Berkeley/1/98, A/HongKong/503/97,A/Nanchang /16A/98,A/PR8/34 and New Caledoniastrain.
SPECIES REACTIVITY:
Reacts strongly with the following H1N1 strain: Beijing. A/ Texas /36/91, A/Berkeley/1/98, A/HongKong/503/97,A/Nanchang /16A/98,A/PR8/34 and New Caledoniastrain.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Preparation Note
Store at 2° to 8°C for up to 12 months from date of receipt.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Sialylneolacto-N-tetraose c (LSTc)-bearing liposomal decoys capture influenza A virus.
Hendricks, GL; Weirich, KL; Viswanathan, K; Li, J; Shriver, ZH; Ashour, J; Ploegh et al.
The Journal of Biological Chemistry null
Evolution of the influenza A virus genome during development of oseltamivir resistance in vitro.
Renzette, N; Caffrey, DR; Zeldovich, KB; Liu, P; Gallagher, GR; Aiello, D; Porter et al.
Journal of virology null
Kristina L Prachanronarong et al.
Journal of virology, 93(2) (2018-11-02)
Influenza A virus (IAV), a major cause of human morbidity and mortality, continuously evolves in response to selective pressures. Stem-directed, broadly neutralizing antibodies (sBnAbs) targeting the influenza virus hemagglutinin (HA) are a promising therapeutic strategy, but neutralization escape mutants can
Li Jiang et al.
Journal of virology, 96(6), e0198221-e0198221 (2022-01-20)
Many oseltamivir resistance mutations exhibit fitness defects in the absence of drug pressure that hinders their propagation in hosts. Secondary permissive mutations can rescue fitness defects and facilitate the segregation of resistance mutations in viral populations. Previous studies have identified
Shaopeng Wang et al.
Proceedings of the National Academy of Sciences of the United States of America, 107(37), 16028-16032 (2010-08-28)
We report on label-free imaging, detection, and mass/size measurement of single viral particles in solution by high-resolution surface plasmon resonance microscopy. Diffraction of propagating plasmon waves along a metal surface by the viral particles creates images of the individual particles
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持